Genetic and environmental factors are involved in pulmonary<unk>  (PH); therefore, not all cases of PH are preventable. PH that is secondary to other diseases such as left heart failure, chronic lung disease, chronic liver disease, and collagen vascular diseases among others can be prevented by the early and optimal treatment of these medical conditions.  Patients who are at an elevated risk for developing pulmonary arterial<unk>  (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with systemic sclerosis or with genetic predisposition.
Pulmonary hypertension primary prevention
Pulmonary hypertension secondary prevention
Pulmonary edema primary prevention
Right heart failure future or investigational therapies
Atelectasis secondary prevention
Atelectasis primary prevention
Bronchiolitis primary prevention
Bronchitis primary prevention